Valcyte (valganciclovir) - Roche, Mitsubishi Tanabe
Keytruda (pembrolizumab) - Merck (MSD)
nanatinostat (VRx-3996) - Viracta Therap
https://www.prnewswire.com/news-releases/viracta-therapeutics-announces-fda-clearance-of-ind-application-for-phase-1b2-trial-in-epstein-barr-virus-positive-ebv-solid-tumors-301338482.html
 
Jul 21, 2021
 
Prev Next